Maximus, Inc. $MMS Stock Position Raised by LSV Asset Management

LSV Asset Management lifted its stake in Maximus, Inc. (NYSE:MMS) by 112.1% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 120,700 shares of the health services provider’s stock after purchasing an additional 63,800 shares during the quarter. LSV Asset Management’s holdings in Maximus were worth $11,028,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Arizona State Retirement System boosted its holdings in shares of Maximus by 0.9% in the third quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock worth $1,524,000 after buying an additional 156 shares during the period. Parkside Financial Bank & Trust lifted its position in shares of Maximus by 21.7% in the 2nd quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock valued at $62,000 after acquiring an additional 157 shares in the last quarter. GAMMA Investing LLC boosted its stake in Maximus by 13.9% in the 3rd quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock worth $122,000 after purchasing an additional 163 shares during the period. Trust Point Inc. boosted its stake in Maximus by 3.7% in the 3rd quarter. Trust Point Inc. now owns 5,286 shares of the health services provider’s stock worth $483,000 after purchasing an additional 191 shares during the period. Finally, Richardson Financial Services Inc. grew its position in Maximus by 123.1% during the 3rd quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock worth $32,000 after purchasing an additional 192 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Price Performance

Shares of NYSE:MMS opened at $74.75 on Friday. The firm has a market cap of $4.08 billion, a price-to-earnings ratio of 11.38 and a beta of 0.57. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $100.00. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88. The business has a fifty day simple moving average of $89.09 and a 200 day simple moving average of $86.58.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.01. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same period in the prior year, the firm posted $1.61 EPS. The business’s revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, sell-side analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Friday, February 13th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, February 13th. This is a boost from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 annualized dividend and a yield of 1.8%. Maximus’s payout ratio is 18.26%.

Insider Buying and Selling at Maximus

In other Maximus news, CFO David Mutryn purchased 1,000 shares of the business’s stock in a transaction dated Monday, February 9th. The shares were acquired at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the acquisition, the chief financial officer owned 40,037 shares of the company’s stock, valued at $3,027,597.94. This trade represents a 2.56% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Michelle F. Link sold 4,039 shares of Maximus stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the completion of the sale, the insider directly owned 19,542 shares of the company’s stock, valued at approximately $1,697,027.28. The trade was a 17.13% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders acquired 4,231 shares of company stock worth $329,521 over the last ninety days. 1.80% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on MMS shares. Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a report on Sunday. Zacks Research raised Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Maximus in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Strong Buy”.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.